Skip to main content

Advertisement

ADVERTISEMENT

Commentary

Commentary
03/19/2019
We recently reported on the various federal and state initiatives to combat rising drug prices. Now our panel of experts analyze HHS's new measure to curb PBM rebate regulations in order to offset high prices.
We recently reported on the various federal and state initiatives to combat rising drug prices. Now our panel of experts analyze HHS's new measure to curb PBM rebate regulations in order to offset high prices.
We recently reported on the...
03/19/2019
First Report Managed Care
Commentary
03/15/2019
Peter Pitts, former associate commissioner with the FDA and president of the Center for Medicine in the Public Interest, reflects on the recent senate committee hearing where CEOs of the seven top pharma companies were questioned about drug...
Peter Pitts, former associate commissioner with the FDA and president of the Center for Medicine in the Public Interest, reflects on the recent senate committee hearing where CEOs of the seven top pharma companies were questioned about drug...
Peter Pitts, former associate...
03/15/2019
First Report Managed Care

Advertisement

Commentary
02/13/2019
As drug prices continue to be a highly contested topic, First Report Managed Care’s expert Russ J. Spjut, PharmD, offers his own commentary on drug rebates and their contribution to rising costs.
As drug prices continue to be a highly contested topic, First Report Managed Care’s expert Russ J. Spjut, PharmD, offers his own commentary on drug rebates and their contribution to rising costs.
As drug prices continue to be a...
02/13/2019
First Report Managed Care
Commentary
01/31/2019
While the nation undergoes turbulent times surrounding illegal immigration, New York City and California are offering plans to cover undocumented immigrants. First Report Managed Care reached out to its panel of experts for their take on...
While the nation undergoes turbulent times surrounding illegal immigration, New York City and California are offering plans to cover undocumented immigrants. First Report Managed Care reached out to its panel of experts for their take on...
While the nation undergoes...
01/31/2019
First Report Managed Care
Commentary
01/25/2019
Peter Pitts, former associate commissioner with the FDA and president of the Center for Medicine in the Public Interest, discusses recent agreements finalized by the White House, United States, Mexico, and Canada, and he explains why this new...
Peter Pitts, former associate commissioner with the FDA and president of the Center for Medicine in the Public Interest, discusses recent agreements finalized by the White House, United States, Mexico, and Canada, and he explains why this new...
Peter Pitts, former associate...
01/25/2019
First Report Managed Care

Advertisement

Commentary
01/22/2019
In the second installment of this series, Amit Khera, MD, director of Preventive Cardiology and a Professor of Medicine at UT-Southwestern Medical Center in Dallas, discusses lifestyle risk, long-term risk, and genetic cholesterol problems...
In the second installment of this series, Amit Khera, MD, director of Preventive Cardiology and a Professor of Medicine at UT-Southwestern Medical Center in Dallas, discusses lifestyle risk, long-term risk, and genetic cholesterol problems...
In the second installment of...
01/22/2019
First Report Managed Care
Commentary
01/15/2019
Amit Khera, MD, director of Preventive Cardiology and a Professor of Medicine at UT-Southwestern Medical Center in Dallas, explains how patient outcomes impact primary and secondary prevention and related treatment costs.
Amit Khera, MD, director of Preventive Cardiology and a Professor of Medicine at UT-Southwestern Medical Center in Dallas, explains how patient outcomes impact primary and secondary prevention and related treatment costs.
Amit Khera, MD, director of...
01/15/2019
First Report Managed Care
Commentary
01/09/2019
In this expert commentary, Peter Pitts, former associate commissioner of the FDA and president of the Center for Medicine in the Public Interest, examines the implications of recent 2019 drug price increases.
In this expert commentary, Peter Pitts, former associate commissioner of the FDA and president of the Center for Medicine in the Public Interest, examines the implications of recent 2019 drug price increases.
In this expert commentary, Peter...
01/09/2019
First Report Managed Care

Advertisement

Commentary
12/07/2018
We asked experts about Amazon in 2017, but so much has happened since. First Report Managed Care recently sought their updated analysis on the heels of the tech giant’s recent moves.
We asked experts about Amazon in 2017, but so much has happened since. First Report Managed Care recently sought their updated analysis on the heels of the tech giant’s recent moves.
We asked experts about Amazon in...
12/07/2018
First Report Managed Care
Commentary
10/26/2018
Competition within a new class of drugs often leads to a balance between plan coverage and coverage requirements benefiting patients, payers, and manufacturers; so, I wanted to provide an overview of the class landscape today.
Competition within a new class of drugs often leads to a balance between plan coverage and coverage requirements benefiting patients, payers, and manufacturers; so, I wanted to provide an overview of the class landscape today.
Competition within a new class...
10/26/2018
First Report Managed Care

Advertisement